GlassScriptPhysician profile
Melissa Sprinkle
NPI 1396360103
$481.54
in general payments reported to CMS, 2019-2025
12 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.15 · 2022: $28.45 · 2023: $111 · 2024: $83.81 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $117.04 | 2024-2025 | |
| Axsome Therapeutics, INC. | $78.41 | 2025 | Auvelity |
| Sanofi Pasteur INC. | $64.25 | 2021-2023 | |
| Glaxosmithkline, LLC. | $45.53 | 2022-2023 | Bexsero, Pediarix |
| Astrazeneca Pharmaceuticals LP | $34.57 | 2024 | Farxiga, Airsupra |
| Abbvie INC. | $26.40 | 2025 | |
| Dexcom, INC. | $25.48 | 2024 | Dexcom G6 Transmitter |
| Cipher Pharmaceuticals US LLC | $20.37 | 2025 | Natroba, Spinosad |
| Corium, LLC | $18.60 | 2023 | Azstarys |
| Adlon Therapeutics L.P. | $18.28 | 2021 | |
| Pfizer INC. | $17.02 | 2023 | |
| Merck Sharp & Dohme LLC | $15.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Sprinkle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.